Cvs Health (CVS) Capital Expenditures (2009 - 2026)

Cvs Health's Capital Expenditures history runs 18 years deep, the most recent figure standing at $849.0 million for Q1 2026.

• Quarterly Capital Expenditures rose 14.27% year-over-year to $849.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.9 billion (up 4.22% YoY) and the FY2025 annual result came in at $2.8 billion, up 1.83% from the prior year.
• Capital Expenditures was $849.0 million for Q1 2026 at Cvs Health, up from $784.0 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $1.1 billion in Q1 2022 and bottomed at $408.0 million in Q2 2022.
• A 5-year average of $718.8 million and a median of $698.0 million in 2025 frame the typical range for Capital Expenditures.
• Annual changes were most pronounced in 2023 — Capital Expenditures surged 44.85% — and 2024, when it decreased 28.35%.
• Cvs Health's Capital Expenditures stood at $688.0 million in 2022, then soared by 32.41% to $911.0 million in 2023, then dropped by 15.7% to $768.0 million in 2024, then rose by 2.08% to $784.0 million in 2025, then gained by 8.29% to $849.0 million in 2026.
• Business Quant data shows CVS's Capital Expenditures at $849.0 million in Q1 2026, $784.0 million in Q4 2025, and $698.0 million in Q3 2025.